We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment make... Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%. Show more
BIO-TECHNE ANNOUNCES NEXT-GENERATION HIGH THROUGHPUT SIMPLE WESTERN SYSTEM PR Newswire MINNEAPOLIS, July 31, 2024 MINNEAPOLIS, July 31, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH...
BIO-TECHNE ANNOUNCES STRATEGIC INVESTMENT IN SPEAR BIO PR Newswire MINNEAPOLIS, July 29, 2024 MINNEAPOLIS, July 29, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced its...
BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS PR Newswire MINNEAPOLIS, July 15, 2024 MINNEAPOLIS, July 15, 2024 /PRNewswire/...
BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES PR Newswire MINNEAPOLIS, May 31, 2024 MINNEAPOLIS, May 31, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that...
BIO-TECHNE TO HIGHLIGHT MULTIPLE APPLICATIONS OF THE MauriceFlex™ SYSTEM AT THE ANNUAL ASMS CONFERENCE PR Newswire MINNEAPOLIS, May 30, 2024 MINNEAPOLIS, May 30, 2024 /PRNewswire/ -- Bio-Techne...
ScaleReady Announces $20 Million G-Rex® Grant Program for the Advancement of Cell and Gene Therapy (CGT) Development and Manufacturing PR Newswire ST. PAUL, Minn., May 29, 2024 ST. PAUL, Minn...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -3.23932 | -4.00459883793 | 80.89 | 83.62 | 76.94 | 1040321 | 81.10612105 | CS |
4 | 5.99068 | 8.35986603405 | 71.66 | 83.62 | 70.3 | 898722 | 77.85192813 | CS |
12 | -4.48932 | -5.46544923302 | 82.14 | 85.57 | 70.3 | 926748 | 77.6258535 | CS |
26 | 11.74068 | 17.8131998179 | 65.91 | 85.57 | 61.16 | 1031801 | 73.43406843 | CS |
52 | -4.14932 | -5.07251833741 | 81.8 | 85.85 | 51.79 | 1043277 | 70.92576884 | CS |
156 | -44.73432 | -36.5521264861 | 122.385 | 135.9625 | 51.79 | 687403 | 79.1332851 | CS |
260 | 27.10818 | 53.6344264728 | 50.5425 | 135.9625 | 38.7925 | 488039 | 78.05513714 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions